Skip to Main Content
Insider Trading

Last Updated: 6 days, 16 hours ago

David Lucchese has an estimated net worth of at least $10.1 million*, as of Feb. 19, 2025. They own 542,928 shares of EVRI stock. They have sold 141,422 shares of EVRI stock since 2021, for an estimated $2.7 million.

David Lucchese $EVRI SEC Form 4 Insider Trading

David Lucchese has filed a total of 10 insider trades in $EVRI since 2021. Their most recent trade was a sale of 33,344 shares, made on Dec 09, 2024. Their largest trade was a sale of 50,000 shares, made on Sep 27, 2021. We estimate that they now own 542,928 shares of $EVRI, worth an estimated $7.5 million.



Insider Trading at $EVRI

There have been a total of 78 insider trades reported at $EVRI since 2021, with 11,000 shares purchased and 1.0 million shares sold. The most active insider traders in $EVRI stock have been Darren Simmons, David Lucchese, and Mark F. Labay. The most recent trade was a sale of 1,480 shares reported by Darren Simmons (EVP, FinTech Business Leader), made on Dec 12, 2024.



History of Insider Stock Trades by David Lucchese

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
EVRI logo EVRI Sale 33,344 Dec 09, 2024 Dec. 9, 2024, 8:48 p.m.
EVRI logo EVRI Sale 7,582 Dec 09, 2024 Dec. 9, 2024, 8:48 p.m.
EVRI logo EVRI Sale 3,033 Dec 09, 2024 Dec. 9, 2024, 8:48 p.m.
EVRI logo EVRI Sale 1,517 Dec 09, 2024 Dec. 9, 2024, 8:48 p.m.
EVRI logo EVRI Sale 400 Aug 15, 2024 Aug. 15, 2024, 7:26 p.m.
EVRI logo EVRI Sale 4,124 Aug 13, 2024 Aug. 15, 2024, 7:26 p.m.
EVRI logo EVRI Sale 1,792 May 14, 2024 May 14, 2024, 9:06 p.m.
EVRI logo EVRI Sale 1,232 May 14, 2024 May 14, 2024, 9:06 p.m.
EVRI logo EVRI Sale 38,398 Mar 03, 2023 March 7, 2023, 8:41 p.m.
EVRI logo EVRI Sale 50,000 Sep 27, 2021 Sept. 27, 2021, 8 p.m.




$EVRI Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.